HOME >> MEDICINE >> NEWS
Hormone therapy may still offer important health benefits to postmenopausal women

(SACRAMENTO, Calif.) -- Despite the highly publicized closing of the Women's Health Initiative study, the scientific community should not rule out that women may benefit from hormone therapy after menopause, say researchers at UC Davis, Duke and Harvard Universities. Their review of the scientific literature on the biology of estrogens and progestins appears in the May 28 issue of the journal Science.

"It was right to close the Women's Health Initiative trial," said Judith L. Turgeon, professor of internal medicine at UC Davis School of Medicine and senior author of the Science article. "But we should not generalize the results of this trial and overlook the real potential that other forms of hormone therapy may offer to postmenopausal women."

The Women's Health Initiative trials used the steroid formulation most frequently prescribed in the United States at the time, given to women in pill form on a daily basis. New information gleaned from basic research in the biology of ovarian hormones, however, indicates that not all estrogens and progestins are alike, nor do they behave identically in different tissues in the body.

"As our understanding of the biology of these hormones grows, the more we realize how important certain factors are -- such as formulation, dosage, whether they're given by a pill or a patch, and characteristics of women being treated," said co-author Phyllis M. Wise, dean of the division of biological sciences and distinguished professor of neurobiology, physiology and behavior at UC Davis. "More targeted therapies may yield important health benefits."

Estrogens affect many tissues in the body. During natural menopause, which occurs in women at an average age of 51 years, estrogen and progesterone secretion from the ovaries diminish. Afterwards, the risk of coronary heart disease and osteoporosis increases. Stroke and dementia are also associated with aging.

"Estrogens and progestins provi
'"/>

Contact: Carole Gan
916-734-9047
University of California, Davis - Health System
27-May-2004


Page: 1 2 3

Related medicine news :

1. Hormone therapy increases risk of urinary incontinence
2. Hormone therapy controversy raises drug safety issues
3. Endocrine Society and Hormone Foundation call for increased research
4. Hormone may offer hope for treating some behavioral disorders
5. Hormone found to protect bones
6. Hormone released by bone marrow cells may hasten recovery from brain injury
7. Hormones increase side effects, complicate treatment decision for prostate cancer patients
8. Hormones and drugs that control blood pressure also control malaria infection
9. Hormone replacement therapy reviewing the evidence
10. Hormone prompts adult stem cells to differentiate into islet cells
11. Hormone therapy study stopped due to increased breast cancer risk, lack of overall benefit

Post Your Comments:
(Date:5/25/2015)... NY (PRWEB) May 26, 2015 ... honors Dr. Heather Stanley-Christian as ... the Year Circle. She is recognized with this ... the nation's leading networking organization exclusively for professional ... 200 operating local chapters. , "I'm pleased to ...
(Date:5/25/2015)... World Patent Marketing, a vertically integrated ... Little Party Table, a party invention that gives people ... suit their party needs. , "Worldwide indoor and outdoor ... past year. Party Supply Rentals alone are a ... CEO and Creative Director of World Patent Marketing ...
(Date:5/25/2015)... May 25, 2015 According to a ... market growth in hip external fixation market is driven ... U.S. population and advancements in infection prevention technologies. As ... fractures are currently accounting for the largest total number ... with falls and accidents. As a result, the average ...
(Date:5/25/2015)... (PRWEB) May 25, 2015 Thousands ... to move forward in the federal multidistrict litigation ... of Texas. According to a Motion filed on ... to modify the Case Management Order pertaining to ... other things, the Motion seeks the adoption of ...
(Date:5/25/2015)... May 25, 2015 After the sensational ... radical science-based human wellness company Trivedi Master Wellness™ ... from their world-class series titled, “Consciousness is Power.” Presently, ... June 13, 2015 at the routinely allotted time from ... event will be made available to the public and ...
Breaking Medicine News(10 mins):Health News:NAPW Inducts Dr. Heather Stanley-Christian, Systems Chair/Maternal Fetal Medicine at Stroger Hospital, into Its VIP Professional Woman of the Year Circle 2Health News:Party Time - Top Officials Get Excited About World Patent Marketing's New Party Invention For Entertainment 2Health News:Party Time - Top Officials Get Excited About World Patent Marketing's New Party Invention For Entertainment 3Health News:DePuy Synthes and Stryker Lead Orthopedic External Fixation Trauma Device Market Due to Increased Hip Fractures in the U.S. 2Health News:DePuy Synthes and Stryker Lead Orthopedic External Fixation Trauma Device Market Due to Increased Hip Fractures in the U.S. 3Health News:Federal DePuy Pinnacle Hip Lawsuits Move Forward, as Plaintiffs Seek to Modify Order Pertaining to Health Authorizations 2Health News:Federal DePuy Pinnacle Hip Lawsuits Move Forward, as Plaintiffs Seek to Modify Order Pertaining to Health Authorizations 3Health News:Hundreds of People Are Thrilled to Hear that Trivedi Master Wellness™ Promises to Hold Another Workshop in June 2015 2Health News:Hundreds of People Are Thrilled to Hear that Trivedi Master Wellness™ Promises to Hold Another Workshop in June 2015 3
(Date:5/22/2015)... 22, 2015 /CNW/ - More than fifty years ago, Thalidomide ... sickness in expectant mothers. Tragically, Thalidomide caused serious and permanent ... Support has been provided to survivors over the ... Canada in 1991 and settlements from drug ... legal obligation to provide support, we have a clear moral ...
(Date:5/22/2015)... YORK , May 22, 2015 ... of the $13 billion global cardiac rhythm management ... Information.  Kalorama found that Medtronic, St. Jude Medical, ... command 80% of this market segment. The healthcare ... Device Markets , uses 2015 as a base ...
(Date:5/22/2015)... May 22, 2015  RegeneRx Biopharmaceuticals, Inc. (OTCQB: ... peer-reviewed publication of the results of the Company,s ... preservative-free eye drops) for the treatment of dry ... (CAE ® ) model.  The exploratory study was ... were previously disseminated by the Company in a ...
Breaking Medicine Technology:Statement from Minister Ambrose on Thalidomide 2Statement from Minister Ambrose on Thalidomide 3Kalorama: Top Companies Dominate Cardiac Defibrillator Market 2Kalorama: Top Companies Dominate Cardiac Defibrillator Market 3Kalorama: Top Companies Dominate Cardiac Defibrillator Market 4Complete Data from RegeneRx Phase II Dry Eye Trial Published in Current Issue of Clinical Ophthalmology 2Complete Data from RegeneRx Phase II Dry Eye Trial Published in Current Issue of Clinical Ophthalmology 3Complete Data from RegeneRx Phase II Dry Eye Trial Published in Current Issue of Clinical Ophthalmology 4
Cached News: